Shareholders’ Equity (Deficit) (Tables)

12 Months Ended

Dec. 31, 2021

Shareholders’ Equity (Deficit) (Tables) [Line Items]

Schedule of obligated to issue

	December 31, 2021				December 31, 2020
	Amount		Shares		Amount		Shares
Shares issuable to consultants, employees and directors	$	282,347		719,366	$	262,273		2,150,020

Schedule of stock warrants

	2021						2020
				Weighted						Weighted
				Average						Average
				Exercise						Exercise
	Number			Price			Number			Price
Outstanding at beginning of the period		51,352,986		$	0.17			47,056,293		$	0.17
Granted during the period		22,421,026		$	0.39			3,582,873		$	0.20
Contractual adjustments to number of warrant shares during the period		---		$	---			1,949,535		$	0.08
Exercised during the period		(13,637,020	)	$	(0.18	)		(1,185,715	)	$	(0.07	)
Expired during the period		(340,000	)	$	(0.23	)		(50,000	)	$	(0.40	)
Outstanding at end of the period		59,796,992		$	0.25			51,352,986		$	0.17
Exercisable at end of the period		59,796,992		$	0.25			51,352,986		$	0.17
Weighted average remaining life		3.2 years						3.1 years

Schedule of stock options outstanding

Warrants Outstanding								Warrants Exercisable
				Weighted-
				Average		Weighted-				Weighted-
				Remaining		Average				Average
Exercise		Number		Contractual		Exercise		Number		Exercise
Prices		Outstanding		Life (years)		Price		Exercisable		Price
$	0.0001 to 0.09		14,789,573		3.0	$	0.07		14,789,573	$	0.07
$	0.10 to 0.24		9,474,380		2.7	$	0.17		9,474,380	$	0.17
$	0.25 to 0.49		31,666,448		3.3	$	0.31		31,666,448	$	0.31
$	0.50 to 1.05		3,866,591		4.1	$	0.67		3,866,591	$	0.67
$	0.05 to 1.00		59,796,992		3.2	$	0.25		59,796,992	$	0.25

Schedule of fair value of the warrant

	2021	2020
Pricing model utilized	Binomial Lattice	Binomial Lattice
Risk free rate range	0.38% to 0.97%	0.19% to 1.59%
Expected life range (in years)	3.00 to 5.00 years	5.00 years
Volatility range	169.53% to 193.21%	119.69% to 132.19%
Dividend yield	0.00%	0.00%

	2021	2020
Pricing model utilized	Binomial Lattice	Binomial Lattice
Risk free rate range	1.47% to 1.68%	0.54% to 0.63%
Expected life range (in years)	10.0 years	10.0 years
Volatility range	170.44% to 192.25%	117.46% to 134.36%
Dividend yield	0.00%	0.00%

Schedule of financial statements with respect to the Plans

	2021			2020
Total cost of share-based payment plans during the year	$	893,979		$	564,667
Amounts capitalized in deferred equity compensation	$	(165,000	)	$	---
Amounts charged against income for amounts previously capitalized	$	13,750		$	---
Amounts charged against income, before income tax benefit	$	742,729		$	564,667
Amount of related income tax benefit recognized in income	$	---		$	---

Employee Equity Incentive Plan [Member]

Shareholders’ Equity (Deficit) (Tables) [Line Items]

Schedule of stock options outstanding

							Weighted
				Weighted			Average
				Average			Remaining		Aggregate
				Exercise			Contractual		Intrinsic
Stock options	Number			Price			Term (Yrs.)		Value
Outstanding at January 1, 2020		3,269,250		$	0.21			7.7	$	74,320
Granted during the period		60,000		$	0.09
Exercised during the period		---		$	---
Forfeited during the period		(217,500	)	$	(0.26	)
Outstanding at December 31, 2020		3,111,750		$	0.20			6.7	$	40,783
Granted during the period		580,000		$	0.33
Exercised during the period		(145,500	)	$	(0.11	)
Forfeited during the period		(90,000	)	$	(0.19	)
Outstanding at December 31, 2021		3,456,250		$	0.20			6.5	$	873,096
Exercisable at December 31, 2021		2,597,500		$	0.20			6.1	$	710,548

Schedule of nonvested options issued

	2021						2020
				Weighted						Weighted
				Average						Average
				Grant Date						Grant Date
Stock options	Shares			Fair Value			Shares			Fair Value
Nonvested options outstanding at beginning of period		1,044,375		$	0.21			1,636,250		$	0.22
Granted		580,000		$	0.25			60,000		$	0.07
Vested		(707,500	)	$	(0.22	)		(491,875	)	$	(0.21	)
Forfeited		(58,125	)	$	(0.14	)		(160,000	)	$	(0.21	)
Nonvested options outstanding at end of period		858,750		$	0.23			1,044,375		$	0.21

Schedule of stock grant activity

	2021						2020
				Weighted						Weighted
				Average						Average
				Grant Date						Grant Date
Stock Grants	Shares			Fair Value			Shares			Fair Value
Nonvested awards outstanding at beginning of period		200,000		$	0.17			332,500		$	0.17
Granted		1,496,861		$	0.21			791,965		$	0.13
Vested		(1,337,311	)	$	(0.19	)		(836,965	)	$	(0.15	)
Forfeited		(57,500	)	$	(0.16	)		(87,500	)	$	(0.06	)
Nonvested awards outstanding at end of period		302,050		$	0.27			200,000		$	0.17